• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNA甲基化有助于沉默胃癌中linc00086的表达。

DNA methylation contributes to silencing the expression of linc00086 in gastric cancer.

作者信息

Yang Yang, Li Yulong, Zhao Zhenghao, Sun Ruifang, Jiang Qiuyu, Zhao Lingyu, Wang Lumin, Liu Yingxun, Wu Fei, Shi Xingmin, Huang Chen, Shao Yuan

机构信息

School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi 710061, P.R. China.

Department of Gastroenterology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi 710068, P.R. China.

出版信息

Oncol Lett. 2018 Aug;16(2):1931-1936. doi: 10.3892/ol.2018.8868. Epub 2018 Jun 1.

DOI:10.3892/ol.2018.8868
PMID:30008886
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6036505/
Abstract

Previous evidence has revealed that long non-coding RNAs serve important functions in numerous types of cancer when dysregulated, including in gastric cancer (GC). In the present study, reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis was used to detect the expression of small integral membrane protein 10 like 2A (linc00086) in GC tissues and non-cancerous tissues, and the expression of linc00086 in GC cell lines was analyzed. A RT-qPCR assay was used to assess linc00086 expression levels in GC cell lines following treatment with 5-Aza-2'-deoxycytidine (5-aza-dC), which is a DNA methyltransferase inhibitor. Small interfering RNA was used to silence the expression of methyl-CpG binding protein 2 (MeCP2), and then the expression of linc00086 was detected. Linc00086 expression was revealed to be downregulated in GC tissues and GC cell lines. Furthermore, it was revealed that 5-aza-dC induced linc00086 expression in SGC-7901 and MKN45 cells, and analysis of CpG methylation by bisulfite sequencing-polymerase chain reaction demonstrated that DNA methylation may regulate the expression of linc00086. MeCP2 is involved in gene regulation by binding to methylated promoters, and it was revealed that the knockdown of the expression of MeCP2 resulted in a higher expression of linc00086. The present study revealed that DNA methylation regulate the expression of linc00086 in human GC cell lines.

摘要

先前的证据表明,长链非编码RNA在失调时在多种类型的癌症中发挥重要作用,包括胃癌(GC)。在本研究中,采用逆转录定量聚合酶链反应(RT-qPCR)分析检测胃癌组织和癌旁组织中微小整合膜蛋白10样2A(linc00086)的表达,并分析linc00086在胃癌细胞系中的表达。使用RT-qPCR测定法评估经DNA甲基转移酶抑制剂5-氮杂-2'-脱氧胞苷(5-aza-dC)处理后的胃癌细胞系中linc00086的表达水平。使用小干扰RNA沉默甲基化CpG结合蛋白2(MeCP2)的表达,然后检测linc00086的表达。结果显示,linc00086在胃癌组织和胃癌细胞系中表达下调。此外,研究发现5-aza-dC可诱导SGC-7901和MKN45细胞中linc00086的表达,亚硫酸氢盐测序-聚合酶链反应对CpG甲基化的分析表明,DNA甲基化可能调节linc00086的表达。MeCP2通过与甲基化启动子结合参与基因调控,研究发现敲低MeCP_{2}的表达会导致linc00086表达升高。本研究表明,DNA甲基化在人胃癌细胞系中调节linc00086的表达。

相似文献

1
DNA methylation contributes to silencing the expression of linc00086 in gastric cancer.DNA甲基化有助于沉默胃癌中linc00086的表达。
Oncol Lett. 2018 Aug;16(2):1931-1936. doi: 10.3892/ol.2018.8868. Epub 2018 Jun 1.
2
KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.KRAZ 锌指蛋白 382 调节上皮-间充质转化并发挥肿瘤抑制作用,但在胃癌中因 CpG 甲基化而沉默。
Int J Oncol. 2018 Sep;53(3):961-972. doi: 10.3892/ijo.2018.4446. Epub 2018 Jun 19.
3
Methylation-associated silencing of MicroRNA-335 contributes tumor cell invasion and migration by interacting with RASA1 in gastric cancer.微小RNA-335的甲基化相关沉默通过与胃癌中的RASA1相互作用促进肿瘤细胞的侵袭和迁移。
Am J Cancer Res. 2014 Nov 19;4(6):648-62. eCollection 2014.
4
DNA hypermethylation of the vimentin gene inversely correlates with vimentin expression in intestinal- and diffuse-type gastric cancer.波形蛋白基因的DNA高甲基化与肠型和弥漫型胃癌中波形蛋白的表达呈负相关。
Oncol Lett. 2016 Jan;11(1):842-848. doi: 10.3892/ol.2015.3937. Epub 2015 Nov 18.
5
Potential diagnostic and prognostic value of plasma long noncoding RNA LINC00086 and miR-214 expression in gastric cancer.血浆长链非编码 RNA LINC00086 和 miR-214 表达在胃癌中的潜在诊断和预后价值。
Cancer Biomark. 2019;24(2):249-255. doi: 10.3233/CBM-181486.
6
Epigenetic inactivation of FAT4 contributes to gastric field cancerization.FAT4的表观遗传失活促进胃场癌化。
Gastric Cancer. 2017 Jan;20(1):136-145. doi: 10.1007/s10120-016-0593-5. Epub 2016 Jan 20.
7
DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac.紧密连接蛋白6的DNA甲基化通过招募甲基化CpG结合蛋白2并使组蛋白H3乙酰化和组蛋白H4乙酰化去乙酰化来促进乳腺癌细胞的迁移和侵袭。
J Exp Clin Cancer Res. 2016 Jul 26;35(1):120. doi: 10.1186/s13046-016-0396-x.
8
Downregulation of microRNA-27b-3p via aberrant DNA methylation contributes to malignant behavior of gastric cancer cells by targeting GSPT1.miRNA-27b-3p 的下调通过异常的 DNA 甲基化靶向 GSPT1 促进胃癌细胞的恶性行为。
Biomed Pharmacother. 2019 Nov;119:109417. doi: 10.1016/j.biopha.2019.109417. Epub 2019 Sep 17.
9
CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.LNCaP和Tramp - C1前列腺癌细胞系中14 - 3 - 3σ基因表达的CpG岛启动子甲基化和沉默与甲基化CpG结合蛋白MBD2相关。
Oncogene. 2006 Aug 3;25(33):4559-72. doi: 10.1038/sj.onc.1209462. Epub 2006 Jun 19.
10
HOXB13 expression and promoter methylation as a candidate biomarker in gastric cancer.HOXB13表达及启动子甲基化作为胃癌的候选生物标志物
Oncol Lett. 2018 Jun;15(6):8833-8840. doi: 10.3892/ol.2018.8371. Epub 2018 Mar 29.

引用本文的文献

1
Regulatory function of DNA methylation mediated lncRNAs in gastric cancer.DNA甲基化介导的长链非编码RNA在胃癌中的调控作用。
Cancer Cell Int. 2022 Jul 9;22(1):227. doi: 10.1186/s12935-022-02648-1.
2
Hypermethylated long noncoding RNA MEG3 promotes the progression of gastric cancer.高甲基化长链非编码RNA MEG3促进胃癌进展。
Aging (Albany NY). 2019 Oct 4;11(19):8139-8155. doi: 10.18632/aging.102309.

本文引用的文献

1
Long non-coding RNA CCAT2 promotes the breast cancer growth and metastasis by regulating TGF-β signaling pathway.长链非编码 RNA CCAT2 通过调节 TGF-β 信号通路促进乳腺癌的生长和转移。
Eur Rev Med Pharmacol Sci. 2017 Feb;21(4):706-714.
2
Gastric cancer and related epigenetic alterations.胃癌及相关表观遗传改变。
Ecancermedicalscience. 2017 Jan 17;11:714. doi: 10.3332/ecancer.2017.714. eCollection 2017.
3
MeCP2 Promotes Gastric Cancer Progression Through Regulating FOXF1/Wnt5a/β-Catenin and MYOD1/Caspase-3 Signaling Pathways.MeCP2 通过调控 FOXF1/Wnt5a/β-catenin 和 MYOD1/Caspase-3 信号通路促进胃癌进展。
EBioMedicine. 2017 Feb;16:87-100. doi: 10.1016/j.ebiom.2017.01.021. Epub 2017 Jan 17.
4
Long Non-Coding RNA BANCR Promotes Endometrial Cancer Cell Proliferation and Invasion by Regulating MMP2 and MMP1 via ERK/MAPK Signaling Pathway.长链非编码RNA BANCR通过ERK/MAPK信号通路调控MMP2和MMP1促进子宫内膜癌细胞的增殖和侵袭。
Cell Physiol Biochem. 2016;40(3-4):644-656. doi: 10.1159/000452577. Epub 2016 Nov 30.
5
Long noncoding RNA PVT1 as a novel serum biomarker for detection of cervical cancer.长链非编码RNA PVT1作为检测宫颈癌的新型血清生物标志物
Eur Rev Med Pharmacol Sci. 2016 Oct;20(19):3980-3986.
6
Fatty acid synthase is a primary target of MiR-15a and MiR-16-1 in breast cancer.脂肪酸合酶是乳腺癌中MiR-15a和MiR-16-1的主要作用靶点。
Oncotarget. 2016 Nov 29;7(48):78566-78576. doi: 10.18632/oncotarget.12479.
7
Long noncoding RNA CCDC26 as a potential predictor biomarker contributes to tumorigenesis in pancreatic cancer.长链非编码 RNA CCDC26 作为一种潜在的预测生物标志物,促进胰腺癌的肿瘤发生。
Biomed Pharmacother. 2016 Oct;83:712-717. doi: 10.1016/j.biopha.2016.06.059. Epub 2016 Jul 29.
8
Methylation of S100A8 is a promising diagnosis and prognostic marker in hepatocellular carcinoma.S100A8的甲基化是肝细胞癌中一种很有前景的诊断和预后标志物。
Oncotarget. 2016 Aug 30;7(35):56798-56810. doi: 10.18632/oncotarget.10792.
9
Aberrant methylation of PCDH10 and RASSF1A genes in blood samples for non-invasive diagnosis and prognostic assessment of gastric cancer.血液样本中PCDH10和RASSF1A基因的异常甲基化用于胃癌的非侵入性诊断和预后评估
PeerJ. 2016 Jun 9;4:e2112. doi: 10.7717/peerj.2112. eCollection 2016.
10
MECP2 promotes the growth of gastric cancer cells by suppressing miR-338-mediated antiproliferative effect.MECP2通过抑制miR-338介导的抗增殖作用促进胃癌细胞生长。
Oncotarget. 2016 Jun 7;7(23):34845-59. doi: 10.18632/oncotarget.9197.